Found: 7
Select item for more details and to access through your institution.
Safety, Tolerability, and Antihypertensive Effect of SER100, an Opiate Receptor‐Like 1 (ORL‐1) Partial Agonist, in Patients With Isolated Systolic Hypertension.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 584, doi. 10.1002/cpdd.330
- By:
- Publication type:
- Article
Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137258
- By:
- Publication type:
- Article
Treatment with a Barrier-strengthening Moisturizer Prevents Relapse of Hand Eczema: An Open, Randomized, Prospective, Parallel Group Study.
- Published in:
- Acta Dermato-Venereologica, 2010, v. 90, n. 6, p. 602, doi. 10.2340/00015555-0964
- By:
- Publication type:
- Article
A Randomized, Double-blind, Placebo-controlled Clinical Study to Investigate the Efficacy of Herring Roe Oil for Treatment of Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2020, v. 100, n. 5, p. 1, doi. 10.2340/00015555-3507
- By:
- Publication type:
- Article
Correction: Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146633
- By:
- Publication type:
- Article
NC100100, a new echo contrast agent for the assessment of myocardial perfusion-safety and comparison with technetium-99m sestamibi single-photon emission computed tomography in a randomized multicenter study.
- Published in:
- Clinical Cardiology, 1999, v. 22, n. 4, p. 273, doi. 10.1002/clc.4960220405
- By:
- Publication type:
- Article
An approach to combining parallel and cross-over trials with and without run-in periods using individual patient data.
- Published in:
- Clinical Trials, 2012, v. 9, n. 2, p. 164, doi. 10.1177/1740774511430714
- By:
- Publication type:
- Article